Is Palantir Stock Overvalued?
By every traditional yardstick, including a price‑to‑sales well above 100,…
Sell
19
CTTH Quote, Financials, Valuation and Earnings
Last price:
$0.0300
Seasonality move
:
-14.22%
Day range:
$0.0170 - $0.0340
52-week range:
$0.0170 - $0.1518
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.58x
Volume:
587.2K
Avg. volume:
109.8K
1-year change:
-33.78%
Market cap:
$1.7M
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CTTH
CTT Pharmaceutical Holdings
|
-- | -- | -- | -- | -- |
|
BLMH
Blum Holdings
|
-- | -- | -- | -- | -- |
|
HEWA
HealthWarehouse.com
|
-- | -- | -- | -- | -- |
|
SNYR
Synergy CHC
|
-- | -- | -- | -- | -- |
|
SSY
SunLink Health Systems
|
-- | -- | -- | -- | -- |
|
WBA
Walgreens Boots Alliance
|
$37B | $0.25 | 1.01% | -14.63% | $12.41 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CTTH
CTT Pharmaceutical Holdings
|
$0.0298 | -- | $1.7M | -- | $0.00 | 0% | -- |
|
BLMH
Blum Holdings
|
$0.68 | -- | $6.6M | -- | $0.00 | 0% | 0.55x |
|
HEWA
HealthWarehouse.com
|
$0.09 | -- | $4.9M | -- | $0.00 | 0% | 0.20x |
|
SNYR
Synergy CHC
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
SSY
SunLink Health Systems
|
$0.98 | -- | $6.9M | 4.08x | $0.00 | 0% | 0.22x |
|
WBA
Walgreens Boots Alliance
|
$11.39 | $12.41 | $9.8B | -- | $0.25 | 8.78% | 0.06x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CTTH
CTT Pharmaceutical Holdings
|
-- | 8.614 | -- | -- |
|
BLMH
Blum Holdings
|
-52.73% | -0.797 | 285.26% | 0.04x |
|
HEWA
HealthWarehouse.com
|
-103.33% | -0.042 | 119.33% | 0.32x |
|
SNYR
Synergy CHC
|
-- | 0.000 | -- | -- |
|
SSY
SunLink Health Systems
|
-- | 0.261 | -- | 2.97x |
|
WBA
Walgreens Boots Alliance
|
52.99% | -0.999 | 85.46% | 0.27x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CTTH
CTT Pharmaceutical Holdings
|
-- | -- | -- | -- | -- | -- |
|
BLMH
Blum Holdings
|
$2.4M | -$1.8M | -- | -- | -58% | -- |
|
HEWA
HealthWarehouse.com
|
$3.8M | $137.7K | -- | -- | 1.49% | $153.8K |
|
SNYR
Synergy CHC
|
-- | -- | -- | -- | -- | -- |
|
SSY
SunLink Health Systems
|
$2.7M | -$683K | 12.24% | 12.24% | -9.33% | -$654K |
|
WBA
Walgreens Boots Alliance
|
$6.9B | -$2B | -27.39% | -46.98% | -10.67% | -$418M |
CTT Pharmaceutical Holdings vs. Competitors
-
Which has Higher Returns CTTH or BLMH?
Blum Holdings has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -76.63%. CTT Pharmaceutical Holdings's return on equity of -- beat Blum Holdings's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CTTHCTT Pharmaceutical Holdings-- -- -- BLMHBlum Holdings56.1% -$0.40 -$18.3M -
What do Analysts Say About CTTH or BLMH?
CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Blum Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than Blum Holdings, analysts believe CTT Pharmaceutical Holdings is more attractive than Blum Holdings.
Company Buy Ratings Hold Ratings Sell Ratings CTTHCTT Pharmaceutical Holdings0 0 0 BLMHBlum Holdings0 0 0 -
Is CTTH or BLMH More Risky?
CTT Pharmaceutical Holdings has a beta of 0.906, which suggesting that the stock is 9.444% less volatile than S&P 500. In comparison Blum Holdings has a beta of 2.726, suggesting its more volatile than the S&P 500 by 172.578%.
-
Which is a Better Dividend Stock CTTH or BLMH?
CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Blum Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Blum Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTTH or BLMH?
CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Blum Holdings quarterly revenues of $4.4M. CTT Pharmaceutical Holdings's net income of -- is lower than Blum Holdings's net income of -$3.3M. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Blum Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.55x for Blum Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTTHCTT Pharmaceutical Holdings-- -- -- -- BLMHBlum Holdings0.55x -- $4.4M -$3.3M
-
Which has Higher Returns CTTH or HEWA?
HealthWarehouse.com has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of 0.82%. CTT Pharmaceutical Holdings's return on equity of -- beat HealthWarehouse.com's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CTTHCTT Pharmaceutical Holdings-- -- -- HEWAHealthWarehouse.com42% -$0.00 -$2.1M -
What do Analysts Say About CTTH or HEWA?
CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand HealthWarehouse.com has an analysts' consensus of -- which suggests that it could grow by 637.8%. Given that HealthWarehouse.com has higher upside potential than CTT Pharmaceutical Holdings, analysts believe HealthWarehouse.com is more attractive than CTT Pharmaceutical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings CTTHCTT Pharmaceutical Holdings0 0 0 HEWAHealthWarehouse.com0 0 0 -
Is CTTH or HEWA More Risky?
CTT Pharmaceutical Holdings has a beta of 0.906, which suggesting that the stock is 9.444% less volatile than S&P 500. In comparison HealthWarehouse.com has a beta of 0.243, suggesting its less volatile than the S&P 500 by 75.721%.
-
Which is a Better Dividend Stock CTTH or HEWA?
CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthWarehouse.com offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. HealthWarehouse.com pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTTH or HEWA?
CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than HealthWarehouse.com quarterly revenues of $9M. CTT Pharmaceutical Holdings's net income of -- is lower than HealthWarehouse.com's net income of $73.8K. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while HealthWarehouse.com's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.20x for HealthWarehouse.com. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTTHCTT Pharmaceutical Holdings-- -- -- -- HEWAHealthWarehouse.com0.20x -- $9M $73.8K
-
Which has Higher Returns CTTH or SNYR?
Synergy CHC has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of --. CTT Pharmaceutical Holdings's return on equity of -- beat Synergy CHC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CTTHCTT Pharmaceutical Holdings-- -- -- SNYRSynergy CHC-- -- -- -
What do Analysts Say About CTTH or SNYR?
CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than Synergy CHC, analysts believe CTT Pharmaceutical Holdings is more attractive than Synergy CHC.
Company Buy Ratings Hold Ratings Sell Ratings CTTHCTT Pharmaceutical Holdings0 0 0 SNYRSynergy CHC0 0 0 -
Is CTTH or SNYR More Risky?
CTT Pharmaceutical Holdings has a beta of 0.906, which suggesting that the stock is 9.444% less volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CTTH or SNYR?
CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTTH or SNYR?
CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Synergy CHC quarterly revenues of --. CTT Pharmaceutical Holdings's net income of -- is lower than Synergy CHC's net income of --. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTTHCTT Pharmaceutical Holdings-- -- -- -- SNYRSynergy CHC-- -- -- --
-
Which has Higher Returns CTTH or SSY?
SunLink Health Systems has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -9.16%. CTT Pharmaceutical Holdings's return on equity of -- beat SunLink Health Systems's return on equity of 12.24%.
Company Gross Margin Earnings Per Share Invested Capital CTTHCTT Pharmaceutical Holdings-- -- -- SSYSunLink Health Systems37.14% -$0.10 $13.4M -
What do Analysts Say About CTTH or SSY?
CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings has higher upside potential than SunLink Health Systems, analysts believe CTT Pharmaceutical Holdings is more attractive than SunLink Health Systems.
Company Buy Ratings Hold Ratings Sell Ratings CTTHCTT Pharmaceutical Holdings0 0 0 SSYSunLink Health Systems0 0 0 -
Is CTTH or SSY More Risky?
CTT Pharmaceutical Holdings has a beta of 0.906, which suggesting that the stock is 9.444% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.124, suggesting its more volatile than the S&P 500 by 12.415%.
-
Which is a Better Dividend Stock CTTH or SSY?
CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTTH or SSY?
CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than SunLink Health Systems quarterly revenues of $7.3M. CTT Pharmaceutical Holdings's net income of -- is lower than SunLink Health Systems's net income of -$671K. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is 4.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.22x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTTHCTT Pharmaceutical Holdings-- -- -- -- SSYSunLink Health Systems0.22x 4.08x $7.3M -$671K
-
Which has Higher Returns CTTH or WBA?
Walgreens Boots Alliance has a net margin of -- compared to CTT Pharmaceutical Holdings's net margin of -7.39%. CTT Pharmaceutical Holdings's return on equity of -- beat Walgreens Boots Alliance's return on equity of -46.98%.
Company Gross Margin Earnings Per Share Invested Capital CTTHCTT Pharmaceutical Holdings-- -- -- WBAWalgreens Boots Alliance17.97% -$3.30 $15.3B -
What do Analysts Say About CTTH or WBA?
CTT Pharmaceutical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Walgreens Boots Alliance has an analysts' consensus of $12.41 which suggests that it could grow by 8.99%. Given that Walgreens Boots Alliance has higher upside potential than CTT Pharmaceutical Holdings, analysts believe Walgreens Boots Alliance is more attractive than CTT Pharmaceutical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings CTTHCTT Pharmaceutical Holdings0 0 0 WBAWalgreens Boots Alliance2 11 1 -
Is CTTH or WBA More Risky?
CTT Pharmaceutical Holdings has a beta of 0.906, which suggesting that the stock is 9.444% less volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.776, suggesting its less volatile than the S&P 500 by 22.379%.
-
Which is a Better Dividend Stock CTTH or WBA?
CTT Pharmaceutical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 8.78% to investors and pays a quarterly dividend of $0.25 per share. CTT Pharmaceutical Holdings pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.
-
Which has Better Financial Ratios CTTH or WBA?
CTT Pharmaceutical Holdings quarterly revenues are --, which are smaller than Walgreens Boots Alliance quarterly revenues of $38.6B. CTT Pharmaceutical Holdings's net income of -- is lower than Walgreens Boots Alliance's net income of -$2.9B. Notably, CTT Pharmaceutical Holdings's price-to-earnings ratio is -- while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings is -- versus 0.06x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTTHCTT Pharmaceutical Holdings-- -- -- -- WBAWalgreens Boots Alliance0.06x -- $38.6B -$2.9B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Gamestop’s Bitcoin Strategy Going To Succeed?
When GameStop (NYSE: GME) announced in Q1 that its board had…
How High Will Roku Stock Go?
Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
11
VEON alert for Jun 14
VEON [VEON] is down 18.57% over the past day.
Buy
74
DAVE alert for Jun 14
Dave [DAVE] is down 12.68% over the past day.
Buy
54
DAR alert for Jun 14
Darling Ingredients [DAR] is up 9.12% over the past day.
